IP Library Granted Patent US 8,740,765
Granted Patent B1
US 8,740,765 · App. 13/571,833 · Granted Jun 3, 2014

Magnetic pulsing system for inducing electric currents in a human body

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,740,765
App. No.
13/571,833
Granted
Jun 3, 2014
Kind
B1
Abstract

Disclosed is a means and method for the treatment of migraine headaches and other disorders of the human body by the application of one or more intense magnetic pulses. By placing an intense magnetic field pulse(s) onto a certain region of the brain, an electrical current can be generated in the cerebral cortex that can stop a migraine headache in some patients or at least decrease its severity. The device to perform this function can be called a “magnetic pulser system.” This system can be made in one piece and powered by plugging into a household or automobile receptacle or from a battery. The pulser system uses capacitors that are first charged to a high voltage and then discharged into a coil that creates the intense magnetic pulse. Both visual and auditory signals can be provided by the pulser system to assist the patient in using the device.

Claims (33)

1. A portable magnetic pulser system for the treatment of migraine headaches of a human subject who is a migraine headache patient, the system including:

an electrical power source for operating the system;

electronic circuitry located within an enclosure for taking power from the electrical power source for charging at least one capacitor;

control circuitry located within said enclosure that is capable of charging the at least one capacitor and then dumping the charge into a magnetic coil that is used to create an intense magnetic pulse onto the brain of the human subject, the charging of the capacitors and the discharge of the capacitors into the magnetic coil being individually controllable by at least one electrical switch that is operated by the patient, the maximum intensity of the magnetic pulse delivered onto the brain of the human subject being between 0.05 and 5.0 Tesla;

a processor mounted within said enclosure, said processor coupled to the electronic circuitry and the control circuitry, the processor configured to:

(1) limit the total number of magnetic pulse treatment sessions that the patient can apply to himself or herself over a period of time before a prescription expires;

(2) calculate a remaining number of pulse treatment sessions which may be applied before a prescription expires; and

(3) disable said magnetic pulser system when said enclosure is at least partially opened; and

a means to indicate the number of pulses remaining for the patient's use in a selective time interval.

2. The magnetic pulser system of claim 1 where there is an audio signal indicating that the magnetic pulser system is not operating properly.

3. The magnetic pulser system of claim 1 including means for refilling the number of pulses remaining for the patient's use based upon a prescription from the human subject's doctor.

4. The magnetic pulser system of claim 3 where the means for refilling is accomplished over a telephone line from a manufacturer's service center.

5. The magnetic pulser system of claim 3 where the means for refilling is accomplished using a USB key.

6. The magnetic pulser system of claim 5 where the USB key can have the number of pulses to be added made available through the USB port of a computer that is in contact over the Internet with a manufacturer's service center.

7. The magnetic pulser system of claim 1 also including means for date and time stamping of each magnetic pulse that is triggered, the data being stored in a digital memory of the magnetic pulser system.

8. A method for the treatment of a disorder of a human patient, the method including the following steps:

a) procuring a magnetic pulser system that is capable of delivering a magnetic pulse having a maximum magnetic field intensity that lies between 0.05 and 5.0 Tesla;

b) sensing by the patient when an illness occurs;

c) having the patient initiate the charging of at least one capacitor in the magnetic pulser system to a high enough voltage to generate the desired magnetic pulse upon an affirmative determination by the magnetic pulser system that the prescribed number of treatment sessions has not been exceeded;

d) placing by the patient of a magnetic coil onto a region in close proximity to a specific problematic nerve of the human body, these specific nerves including at least one nerve selected from: the occipital nerve, carotid sinus and the vagal nerve in the neck; and

e) triggering by the patient of the capacitors to directly discharge into the magnetic coil to provide the desired magnetic pulse to the specific problematic nerve;

wherein a processor mounted within an enclosure is configured to disable said magnetic pulser system when said enclosure is at least partially opened.

9. A portable magnetic pulser system for the treatment of migraine headaches of a human subject who is a migraine patient, the system including:

an electrical power source for operating the system;

electronic circuitry located within an enclosure for taking power from the electrical power source for charging at least one capacitor;

control circuitry located within said enclosure that is capable of charging the at least one capacitor and then dumping the charge into a magnetic coil that is used to create an intense magnetic pulse onto the brain of the human subject, the charging of the capacitors and the discharge of the capacitors into the magnetic coil being individually controllable by at least one electrical switch that is operated by the patient, the maximum intensity of the magnetic pulse delivered onto the brain of the human subject being between 0.05 and 5.0 Tesla;

a processor mounted within said enclosure, said processor coupled to the electronic circuitry and the control circuitry, the processor configured to indicate to the patient that the at least one capacitor is charged so that it is ready to be discharged into the magnetic coil, and further configured to limit the total number of magnetic pulse treatment sessions that the patient can apply to himself or herself over a period of time before a prescription expires; and

a means to indicate the number of pulses remaining for the patient's use in a selective time interval;

wherein said processor is configured to disable said magnetic pulser system when said enclosure is at least partially opened.

10. The magnetic pulser system of claim 9 where the processor indicates that the capacitor is ready to be discharged via a visual means.

11. The magnetic pulser system of claim 10 where the visual means is the filling of a bar that is steadily filled as the capacitor is being charged and is fully illuminated when the capacitor is ready to be discharged.

12. The magnetic pulser system of claim 9 where the processor indicates that the capacitor is ready to be discharged via an audio means.

13. The magnetic pulser system of claim 12 where the audio means is a voice indicating that the capacitor is ready to be discharged.

Assignments (10)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR JEFFREY L. BURTCH AS CHAPTER 7 TRUSTEE OF THE BANKRUPTCY ESTATE OF ENEURA, INC. PREVIOUSLY RECORDED AT REEL: 059221 FRAME: 0245. ASSIGNOR(S) HEREBY CONFIRMS THE BANKRUPTCY . Recorded Apr 8, 2022
From: ENEURA, INC., BY JEFFREY L. BURTCH AS CHAPTER 7 TRUSTEE OF THE BANKRUPTCY ESTATE OF ENEURA, INC.
To: ARUENE CORPORATION
Reel/Frame 059684/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2022
From: BURTCH, JEFFREY L.
To: ARUENE CORPORATION
Reel/Frame 059221/0245 →
SECURITY INTEREST Recorded Oct 31, 2019
From: ENEURA, INC.
To: CAMDEN PARTNERS NEXUS FUND, L.P.; WORLD TOTAL RETURN FUND, LLLP
Reel/Frame 051827/0637 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2019
From: ORTHOFIX, INC.
To: ENEURA, INC.
Reel/Frame 050859/0403 →
CHANGE OF NAME Recorded Mar 15, 2016
From: NEURALIEVE, LLC
To: ENEURA THERAPEUTICS LLC
Reel/Frame 038087/0055 →
MERGER AND CHANGE OF NAME Recorded Mar 15, 2016
From: NEURALIEVE, INC.; NEURALIEVE, LLC
To: NEURALIEVE, LLC
Reel/Frame 038087/0037 →
CHANGE OF NAME Recorded Mar 15, 2016
From: ENEURA THERAPEUTICS LLC
To: ENEURA, INC.
Reel/Frame 038087/0088 →
SECURITY INTEREST Recorded Mar 6, 2015
From: ENEURA, INC.
To: ORTHOFIX, INC.
Reel/Frame 035108/0180 →
CHANGE OF NAME Recorded Feb 17, 2015
From: NEURALIEVE, INC.
To: NEURALIEVE, LLC
Reel/Frame 034969/0902 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2012
From: FISCHELL, ROBERT E.; FISCHELL, SCOTT S.J.; FISCHELL,DAVID R.; MA, EMILY; CHANG, KUEN; VONDLE, DAVE; PLESS, BENJAMIN
To: NEURALIEVE, INC.
Reel/Frame 029444/0267 →